Serizawa; Hiroaki

Patent Applications and Registrations

Patent applications and USPTO patent grants for Serizawa; Hiroaki.The latest application filed is for "treatment of skin disorders by topical administration of vegf inhibitors".

Company Profile

2.3.23

Serizawa; Hiroaki - Palo Alto CA
Serizawa; Hiroaki - Menlo Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Treatment Of Skin Disorders By Topical Administration Of Vegf Inhibitors App 20220249470 - Serizawa; Hiroaki	2022-08-11
Ophthalmic Compositions Of Rifamycins And Uses Thereof App 20210369726 - Serizawa; Hiroaki	2021-12-02
Treatment Of Skin Disorders By Topical Administration Of Vegf Inhibitors App 20210145826 - Serizawa; Hiroaki	2021-05-20
Treatment of skin disorders by topical administration of VEGF inhibitors Grant 10,709,702 - Serizawa	2020-07-14
Ophthalmic Compositions Of Rifamycins And Uses Thereof App 20190255065 - Serizawa; Hiroaki	2019-08-22
Treatment Of Skin Disorders By Topical Administration Of Vegf Inhibitors App 20180289701 - SERIZAWA; Hiroaki	2018-10-11
Ophthalmic Compositions Of Rifamycins And Uses Thereof App 20170202850 - Serizawa; Hiroaki	2017-07-20
Treating neurodegenerative diseases with GGA or a derivative thereof Grant 9,119,808 - Serizawa September 1, 2	2015-09-01
Geranyl geranyl acetone (GGA) derivatives and compositions thereof Grant 9,045,403 - Serizawa , et al. June 2, 2	2015-06-02
Gga And Gga Derivatives Compositions Thereof And Methods For Treating Neurodegenerative Diseases Including Paralysis Including Them App 20150025077 - Serizawa; Hiroaki ; et al.	2015-01-22
Therapeutic uses of geranylgeranyl acetone and derivatives thereof App 20140275280 - Serizawa; Hiroaki ; et al.	2014-09-18
Ocular formulations comprising geranylgeranylacetone derivatives for intraocular delivery App 20140275091 - Serizawa; Hiroaki ; et al.	2014-09-18
Geranylgeranyl acetone and derivatives thereof for intranasal administration App 20140275281 - Serizawa; Hiroaki ; et al.	2014-09-18
Geranylgeranylacetone Formulations And Retinal Delivery Thereof App 20140194527 - Serizawa; Hiroaki	2014-07-10
Geranylgeranylacetone formulations and retinal and systemic delivery thereof App 20140187646 - Serizawa; Hiroaki	2014-07-03
Geranylgeranylacetone Formulations App 20140171516 - Serizawa; Hiroaki	2014-06-19
Gga And Gga Derivatives Compositions Thereof And Methods For Treating Neurodegenerative Diseases Including Paralysis Including Them App 20130296323 - Serizawa; Hiroaki ; et al.	2013-11-07
Transdermal Formulations Of Geranylgeranylacetone App 20130273138 - SERIZAWA; HIROAKI	2013-10-17
Geranylgeranylacetone Formulations And Retinal Delivery Thereof App 20130245126 - Serizawa; Hiroaki	2013-09-19
Geranylgeranylacetone Derivatives App 20130085283 - Serizawa; Hiroaki ; et al.	2013-04-04
Methods For Treating Neurodegenerative Diseases App 20120172453 - Barres; Ben A. ; et al.	2012-07-05

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.